Drug Type Small molecule drug |
Synonyms AGTX-2004, DBPR-211 |
Target |
Mechanism CB1 antagonists(Cannabinoid CB1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prader-Willi Syndrome | Preclinical | US | 15 Sep 2022 | |
Type 2 diabetes mellitus in obese | Preclinical | US | 15 Sep 2022 |